AcouSort Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

AcouSort şirketinin toplam hissedar öz sermayesi SEK15.3M ve toplam borcu SEK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK25.0M ve SEK9.7M dir.

Anahtar bilgiler

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranı	n/a
Nakit	SEK 16.68m
Eşitlik	SEK 15.30m
Toplam yükümlülükler	SEK 9.75m
Toplam varlıklar	SEK 25.04m

Son finansal sağlık güncellemeleri

Recent updates

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

Aug 15

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Nov 25

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Aug 09

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Mar 02

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

May 03

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Jan 18

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ACOU 'nin kısa vadeli varlıkları ( SEK20.9M ) kısa vadeli yükümlülüklerini ( SEK9.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: ACOU un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ACOU borçsuzdur.

Borcun Azaltılması: ACOU son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: ACOU şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: ACOU un, serbest nakit akışı her yıl % 15.1 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

AcouSort Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Recent updates

Second quarter 2024 earnings released: kr0.32 loss per share (vs kr0.24 loss in 2Q 2023)

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) to Report Q3, 2024 Results on Nov 27, 2024

New minor risk - Shareholder dilution

AcouSort AB (publ) has completed a Composite Units Offering.

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.32 loss in 3Q 2022)

New major risk - Share price stability

AcouSort AB (publ) to Report Q4, 2023 Results on Feb 28, 2024

New major risk - Financial position

New minor risk - Share price stability

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

First quarter 2023 earnings released: kr0.23 loss per share (vs kr0.20 loss in 1Q 2022)

AcouSort AB (publ) Launches Next Generation AcouTrap at CYTO 2023

Full year 2022 earnings released: kr0.98 loss per share (vs kr0.92 loss in FY 2021)

Founder & Independent Director recently bought kr68k worth of stock

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Third quarter 2022 earnings released: kr0.32 loss per share (vs kr0.30 loss in 3Q 2021)

Second quarter 2022 earnings released: kr0.31 loss per share (vs kr0.31 loss in 2Q 2021)

The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics

AcouSort AB Announces Executive Appointments

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

AcouSort AB (publ) and Werfen's Joint Patent Application Has Received National Approval in US

AcouSort AB (publ) Announces Scientific Progress with AcouWash Enables New Method for Cancer Treatment Monitoring

First quarter 2022 earnings released: kr0.20 loss per share (vs kr0.15 loss in 1Q 2021)

Founder & Independent Director recently bought kr95k worth of stock

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort will launch AcouWash 2 at international conference

Second quarter 2021 earnings released: kr0.31 loss per share (vs kr0.12 loss in 2Q 2020)

AcouSort AB (publ) Announces Development Process of AcouPlasma Optical Reaches Important Milestone

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.10 loss in 1Q 2020)

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

Acousort Strengthens Commercial Offering with the Release of New Acouwash Application Notes

Full year 2020 earnings released: kr0.70 loss per share (vs kr0.96 loss in FY 2019)

AcouSort AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

AcouSort AB (publ) to Report Q3, 2021 Results on Nov 24, 2021

AcouSort AB Enters Collaboration Agreement with Belgian Diagnostics Company

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Physio-Tech Co.,Ltd. acquired AcouTrap system from AcouSort AB (publ) (OM:ACOU).

New 90-day high: kr26.90

New 90-day high: kr22.30

New 90-day high: kr21.80

Third quarter 2020 earnings released: kr0.20 loss per share

New 90-day high: kr19.25

New 90-day high: kr16.85

New 90-day high: kr12.40

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin